QIAstat-Dx BCID GN与GPF试剂盒直接鉴定血培养瓶及预测耐药性的评估
该研究以常规实验室检测为参考标准,评估QIAstat-Dx BCID GN和GPF研究用试剂盒在阳性血培养瓶中的表现。共纳入174份单微生物血培养,结果显示试剂盒能鉴定目标病原体,检测到的耐药机制对β-内酰胺类耐药具有高度预测性,对非β-内酰胺类耐药的预测则更多变。
要点
- QIAstat-Dx BCID GN和GPF试剂盒可鉴定单微生物血培养中的目标病原体。
- 检测到的耐药机制对β-内酰胺类耐药具有高度预测性。
- 对非β-内酰胺类抗菌药物的耐药预测准确性则较为不一。
核心结论
- QIAstat-Dx BCID GN和GPF试剂盒能鉴定目标病原体,检测到的耐药机制对β-内酰胺类耐药具有高度预测性,但对非β-内酰胺类耐药的预测更多变。
研究设计与样本
- 以常规实验室检测为参考标准,评估QIAstat-Dx BCID GN和GPF研究用试剂盒在阳性血培养瓶中的表现。
主要发现
- 单微生物培养中大多数目标革兰阴性菌被鉴定,仅一株大肠埃希菌未被鉴定为大肠埃希菌,但泛肠杆菌目靶标阳性。
- 单微生物培养中所有目标革兰阳性菌均被鉴定。
- tem/shv检测大肠埃希菌氨苄西林耐药的总体敏感性为94.7%(18/19),特异性为95.8%(23/24)。
- ctx-m和ampC的存在/缺失对大肠埃希菌和肺炎克雷伯菌三代头孢菌素耐药的鉴定具有100%敏感性和特异性。
- blaZ和mecA基因检测组合对金黄色葡萄球菌青霉素和氯唑西林表型药敏结果具有完全预测性。
关键数值与推荐
- tem/shv检测大肠埃希菌氨苄西林耐药:敏感性94.7%(18/19),特异性95.8%(23/24)。
- ctx-m和ampC检测大肠埃希菌和肺炎克雷伯菌三代头孢菌素耐药:敏感性和特异性均为100%。
- blaZ和mecA检测组合对金黄色葡萄球菌青霉素和氯唑西林表型药敏具有完全预测性。
临床怎么用
- 基于初始革兰染色结果选择BCID GN或GPF试剂盒,可快速鉴定目标病原体并预测β-内酰胺类耐药。
- 检测到的tem/shv、ctx-m、ampC、blaZ和mecA等耐药机制结果对β-内酰胺类耐药预测价值高,可辅助临床用药决策。
- 对非β-内酰胺类抗菌药物的耐药预测结果需谨慎解读,可能需结合常规药敏试验。
局限性
- 仅评估了单微生物血培养,未涉及多微生物培养。
- 研究使用研究用(RUO)试剂盒,非商业化诊断版本。
- 非β-内酰胺类抗菌药物的耐药预测准确性不一,未详细报告相关数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Rapid multiplex PCR kits have been used for rapid identification of blood culture isolates and prediction of antimicrobial resistance. We performed an evaluation of the QIAstat-Dx BCID GN and GPF research use only (RUO) kits on positive blood culture bottles using routine laboratory testing as the reference standard. Positive blood culture bottles between November 2023 and January 2024 were tested with QIAstat-Dx BCID GN and GPF kits based on initial Gram stain results and compared against routine identification and phenotypic susceptibility testing. A total of 174 monomicrobial blood cultures were included in the final analysis. The 174 monomicrobial blood cultures composed of 129 BCID GN tests and 45 BCID GPF tests. The majority of on-target Gram-negative organisms in monomicrobial cultures were identified. One Escherichia coli isolate was not identified as such, although the pan-Enterobacterales target was positive. All on-target Gram-positive organisms in monomicrobial cultures were identified. Overall sensitivity and specificity of tem/shv for detection of aminopenicillin resistance in E. coli was 94.7% (18/19) and 95.8% (23/24). The presence/absence of ctx-m and ampC had 100% sensitivity and specificity for identification of third-generation cephalosporin resistance in E. coli and Klebsiella pneumoniae. The combination of blaZ and mecA gene detection was fully predictive of phenotypic susceptibility results to penicillin and cloxacillin for Staphylococcus aureus. Overall, the QIAstat-Dx BCID GN and GPF kits were able to identify on-target pathogens. Detected resistance mechanisms were highly predictive of β-lactam resistance. Prediction of resistance for non-β-lactam antimicrobial was more variable. IMPORTANCE: This is one of the first evaluations of the QIAstat BCID kit and demonstrates high levels of correlation for both identification and antimicrobial resistance prediction.
引用
- Ng S, Tan CY, Yah JY, et al. Evaluation of the QIAstat-Dx BCID GN and GPF kits for direct identification and antimicrobial resistance prediction from blood culture bottles. J Clin Microbiol. 2024. PMID: 39503495. doi:10.1128/jcm.01169-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。